Home » Topics » Regulatory » EMA

EMA
RSS

Cubist's tedizolid phosphate recommended for approval in E.U. for ABSSSI

Jan. 26, 2015

The Medicines Company receives CHMP recommendations for three acute care products

Jan. 26, 2015

European CHMP recommends new approval of Eylea

Jan. 26, 2015

EMA recommends approval of Abraxane for NSCLC

Jan. 26, 2015

EMA committee recommends approval of Saxenda for weight management

Jan. 26, 2015

Jakavi recommended for approval in Europe for polycythemia vera

Jan. 26, 2015

CHMP issues positive opinion for Prevenar 13 for prevention of pneumococcal pneumonia

Jan. 23, 2015

APR-246 receives European orphan drug designation

Jan. 23, 2015

EMA accepts AstraZeneca's lesinurad MAA for gout

Jan. 22, 2015

UCB confirms regulatory filings for antiepileptic drug brivaracetam

Jan. 22, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...